Purdue Pharma, Opioid Settlement
Digest more
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the opioid crisis.
We also found that states that legalized recreational marijuana earliest (for example, in the early 2000s) experience larger decreases in opioid deaths.
Local governments have received hundreds of millions of dollars from the opioid settlements to support addiction treatment, recovery, and prevention efforts.
OxyContin-maker Purdue Pharma can settle claims against it by paying up to $7.4 billion to end cases filed amid the nation's opioid epidemic.